Headline EventAnalyzer: Daily Market Movers (5 Feb 2010)
Source EP Vantage
Company Accuray, Alkermes, BioMarin Pharmaceutical, Daiichi Sankyo, Dainippon Sumitomo Pharma, Medivation, Micromet, NeuroSearch, Ranbaxy Laboratories, ThromboGenics, Valeant Pharmaceuticals International 
Date February 08, 2010
 

EvaluatePharma’s EventAnalyzer delivers a daily global round up of key events driving company valuations.

Detailing the previous day’s top 15 market gains and losses, aligned with significant news flow driving share prices, the EventAnalyzer keeps you in touch with the latest market moves.

You are a Guest User

The remainder of this story is only available to EP Vantage Subscribers.

Please click the following link to register for a free trial of EP Vantage

Register for a free trial

or if you are already a registered user, please Login Now
 

This content is written, edited and published by EP Vantage and is distributed by EvaluatePharma Ltd. All queries regarding the content should be directed to: news@epvantage.com

EP Vantage is a unique, forward-looking, news analysis service tailored to the needs of pharma and finance professionals. EP Vantage focuses on the events that will define the future of companies, products and therapy areas, with detailed financial analysis of events in real-time, including regulatory decisions, product approvals, licensing deals, patent decisions, M&A.

Drawing on EvaluatePharma, an industry-leading database of actual and forecast product sales and financials, EP Vantage gives readers the insight to make value-enhancing decisions.
EP Vantage SM ©2010 EP Vantage Ltd